Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: lots (173), tons (13), heaps (10), masses (61)

Crizanlizumab Ver 1

Description: Chemotherapy Protocol Recurrent Vaso-Occlusive Crises in Sickle Cell Disease CRIZANLIZUMAB Regimen • Recurrent Vaso-Occlusive Crises in Sickle Cell Disease- Crizanlizumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sickle-Cell/Crizanlizumab-Ver-1.pdf

Hepatitis C: information for people who have used drugs - patient information

Description: Hepatitis C is a curable illness which is mainly spread via blood-to-blood contact.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Hepatitis-C-information-for-people-who-have-used-drugs-542-PIL.pdf

Body modification

Description: Nearly twenty years ago, a court was faced with an agonising decision: whether the proposed separation of conjoined twins was lawful
Url: /HealthProfessionals/Clinical-law-updates/Body-modification.aspx

Prof Robert Read, theme lead for microbial science

Description: NIHR Southampton Biomedical Research Centre Auto Generated Title Combining clinical and research expertise, Professor Read is Director-designate of the NIHR
Url: /ClinicalResearchinSouthampton/Our-people/Microbial-science-people/Prof-Robert-Read-theme-lead-for-microbial-science.aspx

Prof Robert Read, director NIHR Southampton Biomedical Research Centre

Description: NIHR Southampton Biomedical Research Centre Auto Generated Title Professor Read is director of the NIHR Southampton Biomedical Research Centre and theme
Url: /ClinicalResearchinSouthampton/Our-people/Directors/Prof-Robert-Read-director-NIHR-Southampton-Biomedical-Research-Centre.aspx

Appendix C - HBIG 200 IU neoanates risk assessment and prescription form

Description: Hepa atitis B Immun noglobulin (H HBIG) for pos st-exposure prophylaxis (PEP) in NEONA ATES born to women with Hepatitis
Url: /Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixC-HBIG200IUNeoanatesRiskAssessmentandPrescriptionForm.pdf

Central slip extensor tendon injury - patient information

Description: This factsheet explains how to care for a central slip extensor tendon injury.
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Central-slip-extensor-tendon-injury-1809-PIL.pdf

Papers Trust Board - 13 January 2026

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

Trastuzumab (21 day-Maintenance)

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB (21 day- Maintenance) Regimen • Breast Cancer – Trastuzumab (21 day-Maintenance) Indication • Adjuvant treatment of breast cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-21-day-Maintenance.pdf

Finance and Performance Reports 2023-24 Month 6 September 2023

Description: Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Finance Report 2023-24 Month 6 12
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Finance-and-Performance-Reports-2023-24-Month-6-September-2023.pdf

41 to 50 of 95

Previous … 3 4 5 6 7 … Next